By Editor , 18 September 2026
Lead Image
Seattle Children's Lands on U.S. News Top 10 List for Third Year Straight

Seattle – September 17, 2026 -- Seattle Children's has secured a spot on U.S. News & World Report's Best Children's Hospitals Honor Roll for the third consecutive year, a recognition given to only 10 hospitals nationwide.

The hospital ranked No. 1 in Washington state and tied for No. 1 in the Pacific region, which covers Alaska, California, Hawaii, Oregon and Washington.

By Editor , 15 September 2026
Lead Image
Cobblestone Car Wash Donates $1 Per Wash to Fight Pediatric Cancer

Boise, Idaho – September 15, 2026 -- Cobblestone Car Wash is donating $1 from every GrapheneX Express Exterior wash purchased at any of its Idaho locations throughout September to St. Luke's Children's Hospital's pediatric cancer research program.

The initiative coincides with Childhood Cancer Awareness Month and applies to all 14 Cobblestone locations across Idaho.

By Editor , 12 September 2026
Lead Image
Free Kidney Patient Summit Hits Little Rock With Free Meals, Meds Talk

Little Rock – September 12, 2026 -- The American Association of Kidney Patients (AAKP) will host its 51st annual National Patient Meeting September 10-13, 2026, in Little Rock, Arkansas, with free admission and meals for kidney patients, family members, care partners, and living organ donors. Pre-registration is encouraged online or by calling (800) 749-2257.

By Editor , 10 September 2026
Lead Image
New Docuseries Exposes Deadly Myths of 'Germanic New Medicine'

Munich – September 09, 2026 -- A new two-part investigative docuseries, "Seelenfänger: Der falsche Heiler," premieres October 13, 2026 in the ARD Mediathek and airs October 19, 2026 at 11:30 p.m. on BR Fernsehen, documenting families who lost loved ones after they trusted the pseudo-medical theory known as "Germanische Neue Medizin" (Germanic New Medicine).

By Editor , 9 September 2026

Somerset, N.J. – September 08, 2026 -- A prostate cancer specialist with more than 30 years of experience says his own diagnosis nearly slipped through the cracks despite a PSA reading that looked normal, a warning he's sharing as ProCure Proton Therapy Center marks National Prostate Cancer Awareness Month.

By Editor , 8 September 2026
Lead Image
Spine Institute Lists Questions Patients Should Ask Before Back Surgery

Hudson, Florida – September 07, 2026 -- The Bonati Spine Institute has published a list of questions it says chronic back and neck pain patients should ask any surgeon proposing spinal surgery, timed to September's Pain Awareness Month.

"Most of the people who come to us have been in pain for years, and most of them have been treated for years," said Dr. Alfred Bonati, founder and chief orthopedic surgeon of the institute. "Many of them have never gotten a straight answer to one basic question: what specifically is generating this pain, and how do you know?"

By Editor , 7 September 2026
Lead Image
30% of Men Over 55 Skip Prostate Cancer Screening, Survey Finds

Columbia, Md. – September 07, 2026 -- A new national survey from MedStar Health finds that 30% of men age 55 and older have never had a prostate exam, and nearly four in ten have skipped the prostate-specific antigen (PSA) blood test, despite prostate cancer being one of the most common cancers in men.

PSA screening is recommended at least every two to four years for average-risk men ages 55 through 69. About one in eight men will be diagnosed with prostate cancer during their lifetime.

By Editor , 7 September 2026
Lead Image
75 Years of Cancer Research Have Given Patients 26 Million Extra Years of Life

Washington – September 07, 2026 -- A new analysis published in Blood Advances finds that treatment advances for leukemia, lymphoma, myeloma and other blood cancers have saved an estimated 25.8 million life-years in the United States since 1949. The study, led by Blood Cancer United, introduces a first-of-its-kind "life-years saved" methodology built on data from the National Cancer Institute's SEER Program, tracking cancer incidence, mortality and U.S. life expectancy from the era of the first chemotherapies through 2024.